Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NY: SNY )

43.41 USD UNCHANGED
Last Price Updated: 5:16 PM EST, Dec 31, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Sanofi-Aventis S.A.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Magenta Is Ready to Paint Your Portfolio Green
This clinical-stage biotech is looking to make stem cell transplantation faster, easier, and safer for both donors and patients. 
Tags SNY AVRO MGTA
From Motley Fool
Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout
Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion just recently wrapped its initial public offering in July. 
From Investor's Business Daily
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
Health Canada has approvedSanofi’s SA(NASDAQ:SNY) andRegeneron Pharmaceuticals ... 
Tags Benzinga News General
From Benzinga
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
The FDA approved expanded use ofRegeneron Pharmaceuticals Inc(NASDAQ:REGN) andSanofi’s ... 
Tags Benzinga Market News General
From Benzinga
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
Amid concerning virus variants, the FDA said it would quickly analyze any vaccine booster shots against COVID-19 variants. The ... 
Tags COVID/19 Vaccine SHTDY CVAC
From Benzinga
Global Exception
Markets fell sharply over concern about high bond yields and potential inflation. 
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
3 Green Flags for Novavax Investors, and 1 Red Flag
Since January 2020, Novavax has become 65-bagger. Is it still a buy? 
Tags Market News SNY PFE
From Motley Fool
Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg
Bristol-Myers Squibb Co(NYSE:BMY) andSanofi SA(NASDAQ:SNY) wereordered to paythe state of ... 
Tags FDA Health Care BMY
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Biotech stocks advanced in the week ended Feb. 12, thanks to market strength and company-specific catalysts. Small and mid-cap earnings, multiple conference presentations, data readouts, and a slew of... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap ... 
Tags VCYT FDA KALV
From Benzinga
Amicus Stock Plunges After Rare-Disease Drug Misses In Key Study
Amicus Therapeutics said Thursday its rare-disease treatment failed to outperform a standard drug on one key measure in a Phase 3 test. In response, FOLD stock plunged on Friday. 
From Investor's Business Daily
What Is Vaxart Worth Now?
The company can still produce returns without a COVID vaccine. 
Tags SNY JNJ VXRT
From Motley Fool
Sanofi Offers Cash Buyout For Kiadis
Sanofi SA(NASDAQ:SNY) haslaunched a takeover offerforKiadis Pharma NV(OTC: KIADF) to represent an ... 
Tags News Biotech KIADF
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ARGX VCYT ITRM
From Benzinga
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Sanofi SA(NASDAQ:SNY) andRegeneron Pharmaceuticals Inc's(NASDAQ:REGN) immunotherapy Libtayo ... 
Tags Biotech News SNY
From Benzinga
A Look Into Sanofi's Price Over Earnings
Looking into the current session, Sanofi Inc. (NASDAQ:SNY) shares are trading at $48.58, after a 0.77% increase. ... 
Tags News SNY Intraday Update
From Benzinga
A Look Into Sanofi's Debt
Over the past three months, shares of Sanofi (NASDAQ:SNY) decreased by 4.51%. Before we understand the importance of debt, let ... 
Tags News BZI/Debt Market News
From Benzinga
Should You Buy Lexicon Pharmaceuticals Stock?
Your portfolio could benefit from its group of soon-to-be-commercialized drugs. 
Tags SNY BMY LXRX
From Motley Fool
Sanofi (SNY) Q4 2020 Earnings Call Transcript
SNY earnings call for the period ending December 31, 2020. 
Tags SNY Market News
From Motley Fool
What's Behind Regeneron's Stellar Q4 Update
The big biotech was firing on all cylinders, and getting strong growth out of its top-selling products. 
Tags SNY REGN Market News
From Motley Fool
Regeneron's Q4 Double-Digit Top and Bottom-Line Growth Propelled By Higher Sales From Eylea And Dupixent
Regeneron Pharmaceuticals Inc(NASDAQ:REGN)reported fourth-quarter earningsof $9.53 per share, which beat the ... 
Tags Market News Earnings Guidance
From Benzinga
Sanofi: Q4 Earnings Insights
Shares of Sanofi (NASDAQ:SNY) rose 2.7% in pre-market trading after the company reported Q4 results. Quarterly ... 
Tags SNY News Earnings
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORGO REGN PLSE
From Benzinga
Sanofi Swings To Forth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By €500M
Sanofi SA(NASDAQ:SNY) posted aprofit for the fourth quarterof 2020 at €1.08 billion, a turnaround from a ... 
Tags SNY Health Care Biotech
From Benzinga
European stocks head for best week since November as investors wait for U.S. jobs data
European equities moved mostly higher on Friday, after a batch of upbeat earnings, while U.S. stock futures inched up ahead of key jobs data. 
Tags FR:SAN JNJ UK:UKX
From MarketWatch
Earnings Scheduled For February 5, 2021
Companies Reporting Before The Bell • Civista Bancshares (NASDAQ:CIVB) is likely to report quarterly earnings at $0.44 ... 
Tags ROAD Earnings ZBH
From Benzinga
Pfizer Is Ready, Even For COVID-19 Variants
This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), ... 
Tags Benzinga PFE Pfizer Corporation (PFE)
From Benzinga
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
Manufacturing the Pfizer and Moderna vaccines is complex; here's where the bottlenecks are. 
Tags XE:BAYN ES:ROVI UK:CRDA
From MarketWatch
2 Growth Stocks for In-the-Know Investors
Right now, most investors are oblivious to OptimizeRX and eXp World Holdings. Here's why you should know their names. 
Tags EXPI Market News AZN
From Motley Fool
Is It Too Late to Buy Pfizer Stock?
Time to buy the drugmaker is running out. 
Tags Market News BNTX PFE
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback